Re: [glaucoma] Info about pigment dispersion and my possible glaucoma - sorta good news...

2007-12-31 21:33:12

Sorry a few typos I corrected:
EqWestArt <eqwestart@...

Hi,
The specialist said I have three things going on:
1. Pigment dispersion that can lead to pigmentary glaucoma.
2. Staphamaloma or something like that where I have nerve cupping and
less healthy nerve tissue that most people.
3. Pitting in one eye that can lead to a detached retina.
He said I do NOT have glaucoma! Good thing I went to see him. However
I will still continue with my other opthamalogist unless I need something
like this again.
I need to keep using Lumigan and keep my pressures under 17 (they are
around 15/16 right now). And I do have thin corneas.
He also said that Lumigan is okay at room temp even if over 77 degrees (he said the package insert directions were old and needed to be updated) - that keeping it cold
is bad for it. Some frigs get below 50 degrees and that ruins it according to
him.
So, I think I did okay for now. He did make it sound like it's likely
I will have future problems but that everything's stable and okay for
now. I'll need to look at a grid chart he gave me twice a week to see if I
have any blurry spots in my vision due to the pitting.
Also, my nerve configuration is CONGENITAL NOT FROM GLAUCOMA! I feel
good and bad at the same time about that.
Oh well, the entire scoop. We'll see what the other regular opthamal I see what she says about his findings. Of course she'll need to concur with them - he's the specialist after all and she's not. Dodged the DMV bullet for now....
Lynn

New to Drops

2007-12-31 20:19:01

I am new to drops: have started on Travatan about a month ago.
So far, no side effects except sometimes a little eye irritation.
A few questions: the instructions say to refrigerate it until
opening, then it's good for 6 weeks. But is it okay to
refrigerate it AFTER opening it? We are having a spell of very
hot weather, and if I don't refrigerate it, the room temperature
is around 85.
Also if I do refrigerate it, should I warm the bottle up a little
with my hands before putting the drops in?
I am at the end of my first bottle. It's been
almost 5 weeks. To be on the safe side, should I throw it out
and open the second new bottle? Or should I keep using it until
done which will probably be another week. There might have
been one or two occasions at the very beginning when the
bottle was under warmer conditions than it should have been.
Do the drops become ineffective, if not maintained at certain
temperatures,or past a certain time frame, or is it just that
bacteria can breed?
Wondering if it would be a good practice to throw them away
at 1 month, just to be on the safe side?
Laurie

Re: [glaucoma] Iridoplasty - here's some good bathtub reading

2007-12-31 07:49:53

Dr. R:

I thought it was dangerous to fall asleep in the tub.

Info about pigment dispersion and my possible glaucoma - sorta good news...

2007-12-31 06:37:10

Hi,
The specialist said I have three things going on:
1. Pigment dispersion that can lead to pigmentary glaucoma.
2. Staphamaloma or something like that where I have nerve cupping and
less healthy nerve tissue that most people.
3. Pitting in one eye that can lead to a detached retina.
He said I do NOT have glaucoma! Good thing I went to see him. However
I will still continue with my other opthamalogist unless I need something
like this again.
I need to keep using Lumigan and keep my pressures under 17 (they are
around 15/16 right now). And I do have thin corneas.
He also said that Lumigan is okay at room temp even if over 77 degrees (he said the package insert directions were old and needed to be updated) - that keeping it cold
is bad for it. Some frigs get below 50 degrees and that ruins it according to
him.
So, I think I did okay for now. He did make it sound like it's likely
I will have future problems but that everything's stable and okay for
now. I'll need to look at a grid chart he gave me twice a week to see if I
have any blurry spots in my vision due to the pitting.
Also, my nerve configuration is CONGENTITAL NOT FROM GLAUCOMA! I feel
good and bad at the same time about that.
Oh well, the entire scoop. We'll see what the other regular opthamal I see says about his findings. Of course she'll need to concur with them - he's the specialist after all and she's not. Dodged the DMV bullet for now....
Lynn

Re: Migraines and glaucoma

2007-12-31 02:17:27

Sherry: I have been taking Travatan for a month:
and I have noticed that although I have had a couple of headaches:
I have had fewer than usual. (at first my doctor gave it to me
in one eye to test its effectiveness: after 2 weeks, the eye
with the drops was 12, the other eye was 19.)
I have never officially been diagnosed with migraines: originally
thought they were PMS, but still have the headaches despite no
longer having periods. I'm going to ask my family practice doctor
whether she thinks they are migraines, or sinus headaches.
Laurie

RE: [glaucoma] Migraines and glaucoma

2007-12-30 20:09:22

In a Wills Glaucoma chat, Dr. Henderer discussed this
P: How much do migraines affect the optic nerve? Would a person have to
have a lot of migraines or do occasional migraines cause a problem?
Dr. Henderer: Migraines are associated with glaucoma, but I have never seen
any data that relates their frequency with glaucoma. I just don't know that
one.
P: I have had migraines since I was a teen-ager, which was long ago, but I
never associated them with my glaucoma, which is primary open angle.
Dr. Henderer: Migraines are associated with glaucoma, but they may not
cause glaucoma. Migraines are a marker for blood vessel spasm and that
spasm may also be a mechanism for glaucoma damage.
http://www.wills-glaucoma.org/supportgroup/20010604.html
in a different chat, Dr. Rick Wilson wrote:
Dr. Rick Wilson: It appears at this time that vascular factors, which
include low blood pressure at all times or just during the night, and
vasospastic diseases, like migraines and Raynaud's, are the chief known risk
factors for NTG (normal tension glaucoma). Other factors include autoimmune
disease, cardiovascular disease, and abnormal blood thickness or clotting.
http://www.wills-glaucoma.org/supportgroup/20040505.php
Sherry

Migraines and glaucoma

2007-12-30 11:26:02

Does anyone know whether migraines help to contribute to
glaucoma damage, or are they just associated in the same way
as in white cats, different colored eyes are sometimes associated
with deafness: the eye color didn't make the cat deaf it's just
on the same gene or something?
Laurie

Re: [glaucoma] Lutein -- Any Use?

2007-12-30 09:58:12

You're right that you have to be selective when buying vitamins, as
some are just worthless - or so I'm told by a friend who has a masters
in nutritional science. There are various good brands but just as a
general rule, Solgar is one of them. They do a lutein and lycopene
capsule.

Re: [glaucoma] Digest Number 1106

2007-12-30 02:56:21

Responding to comment made by miakado@...
Don't let that bother you. Get rid of him. When I was diagnosed with glaucoma, my husband kept complaining about how he did not know what he was going to do if something happened to me. The only way I could get him to shut up was to take out more life insurance on me. I stayed in that miserable marriage for about 3 more years and just kept being pulled down and down by him. By the time I asked him to move out (the house was mine before I met him), it was almost too late to save myself. As I look back now, I can still feel the pain of knowing that he did not care.
I guess one of the most important things that glaucoma has taught me to do, is take better care of myself. And if others don't treat me right, I walk away from them.
So cheer up, you are not alone when you are with this group of people.
Darnell

Re: [glaucoma] Ginkgo Biloba

2007-12-29 20:39:07

Dr. Ritch published a paper on Gingko a few years ago. He thinks it has potential for glaucoma patients. Maybe he will have time to respond to your query.

Dwight

Ginkgo Biloba

2007-12-29 14:16:47

Mathew asked about lutein: what do people think about ginkgo
biloba? Is it any good? I had read that: however: it can cause
bleeding problems in certain people.
Laurie

Lutein -- Any Use?

2007-12-29 07:17:36

Not specifically a Glaucoma question, but I see that Bausch & Lomb have
branched out into the OTC drug business with an antioxidant/lutein capsule.
What's the consensus on Lutein? Are there any serious peer-reviewed studies
that indicate benefits? If so, how do you select a reliable product, with so
many different brands out there?

RE: [glaucoma] Glaucoma and scuba diving

2007-12-29 03:30:57

Ruud,
The best information for *you* will come from *your* glaucoma specialist,
however this has been discussed in the Wed night chats with a doc from the
Wills Glaucoma Service:
"Moderator: Would there be any restrictions for scuba divers and sky divers
who have glaucoma?
Dr. Rick Wilson: Scuba diving causes the oxygen and carbon dioxide
concentration in the blood to rise. The carbon dioxide levels would cause
vasodilation, which would probably be helpful, if anything. High oxygen
saturation would probably not have much effect. The worry would be for
blebs (surgically created drains) and whether the mask could hit the eye and
hurt the bleb. I used to use spit to keep my mask from fogging up, which is
not a good idea for a patient with a bleb. It would be better to use a
commercial defogger or toothpaste."
http://www.wills-glaucoma.org/supportgroup/20011003.html
and
"Moderator: Are there activities besides impact exercise that glaucoma
patients should avoid, such as bowling, scuba diving, mountain climbing?
Dr. Wilson: Impact exercises are only a problem if you have pigment
dispersion syndrome. Scuba diving is fine unless you have a thin bleb from
a trabeculectomy. Most other exercise is excellent."
http://www.wills-glaucoma.org/supportgroup/20010307.html
Sherry

Glaucoma and scuba diving

2007-12-28 11:54:04

Since 1972 I started to learn scuba diving. I am diving every year.

Last year I had Glaucoma on both eyes.

Has some-one experiences about scuba diving and Glaucoma?

Every 10 meters deep will gibe one bar more pressure on my eyes. Normally I don't go deeper than 40 meters, which means that my eyes will have a pressure of maximum 5 bar (4 bar more than normal).

The pressure in my eyes are left 7 and right 12.

Would be grateful for any information.

Ruud

New to Glaucoma- need some information

2007-12-28 10:51:21

Hello everyone,
I might be only or one of the youngest one here. I am a 19 year old
living in New York City. I was told last week that I might have
glaucoma. But my eye pressure is in law 10s. but the doctor told me
that it appers that my optic nerve is demaged. Do anyone know, If I
could have glaucoma with this kind of eye pressure.
I read in some websites, it is usually a dease for people over 40.
Is it possible for me to have it?
Also can anyone tell me name and contact information for a good
glaucoma doctor.
Before last couple of weeks, I didn't know that there were anything
such as glaucoma. But I know about something about glaucoma. I want
more information about glaucoma. Can anyone refear me to any books
or website.
I will appriciate any kind of information.
Hope to hear from you soon.
Very Truly,
Farid
shohelny@...
bestwishes195@...

Re: [glaucoma] New to Glaucoma- need some information

2007-12-28 10:23:56

Farid,

You will find lots of information at this site http://www.wills-glaucoma.org/. I hope it will help you find the information you are seeking.

Carol

---
Outgoing mail is certified Virus Free.
Checked by AVG anti-virus system (http://www.grisoft.com).
Version: 6.0.690 / Virus Database: 451 - Release Date: 5/22/2004

Dr. Ritch in NYC 14th Street

2007-12-28 00:11:28

Ronnie, yes, you are right.
In fact, he is known all over the world, and all good glaucoma specialists, if
don't know him personally, at least, read his articles.
Looker ( a glaucoma sufferer)

RE: [glaucoma] Cutoff point for normal tension glaucoma

2007-12-27 14:44:50

Laurie,
"Normal" pressures range from 12-21mmHg. There's an article on NTG at
http://glaucomafoundation.org/info.php?i=19
I had optic nerve damage progress while my pressures were at 17 on Xalatan -
they were 25 when diagnosed. The glauc doc defined this as "POAG with
normal tension progression"
Sherry

Re: Dr. Ritch in NYC 14th Street

2007-12-27 14:30:38

Dr. Ritch is an excellent excellent doctor. I have seen him and he is considered one of the best!!
Good Luck-
Ronnie Schultz
Gramercy Park
NYC

Cutoff point for normal tension glaucoma

2007-12-27 08:42:25

What is the cutoff point for normal tension glaucoma?
I have been diagnosed with primary open angle glaucoma, and
my optic pressure while it was still treated ranged
(in the morning) from 19 to 21. That's right on the borderline,
isn't it?
Is the treatment/method of dealing with one, different from
dealing with the other? If so, then wouldn't it be important to
find out which I actualy had?
Or on the other hand, are they really the same thing? It sounds
like from what I have read, that the treatment used is the same.
Laurie

Re: Coolers for Keeping Drops at Proper Temperature

2007-12-27 01:22:26

I asked this earlier but got no response - how critical is it to keep
the drops at the recommended 55-77 degrees temp???
i've never even thought about it!
thanks,
lynn

Re: [glaucoma] Coolers for Keeping Drops at Proper Temperature

2007-12-26 18:36:41

Lynn - Find US suppliers and stockists of Frio at www.frio.us.com
Sara

Iridoplasty - here's some good bathtub reading

2007-12-26 06:26:09

Laser Iridotomy and Peripheral Iridoplasty
Robert Ritch, M.D.
Jeffrey M. Liebmann, M.D.
From the Departments of Ophthalmology, The New York Eye and Ear Infirmary, New York, NY and New York Medical College, Valhalla, NY.
Running title: Ritch/Laser iridotomy and iridoplasty
Supported in part by the New York Glaucoma Research Foundation
Corresponding author: Robert Ritch, MD, Professor and Chief, Glaucoma Service, the New York Eye and Ear Infirmary, 310 East 14th Street, New York, NY 10003, Tel: 212-673-5140; FAX: 212-420-8743; e-mail: ritch@inx.net
HISTORICAL OVERVIEW
In 1916, Verhoeff and Bell[Verhoef, 1916 #1350] first focused sunlight on the iris and retina. In 1956, Meyer-Schwickerath[Meyer-Schwickerath, #1352] first reported the creation of a patent iridotomy using the xenon arc photocoagulator. Patent iridotomies were created in 1958 using high-intensity radiant energy from a copper-coated carbon arc.[McDonald, 1958 #1351] These and other[Hogan, 1960 #1353; Burns, 1965 #1354] early attempts at thermal iridotomy were characterized by a high rate of complications, such as lens opacity and inflammation.
The advent of laser technology enabled the use of monochromatic focused light. Iridotomy using the pulsed ruby laser required less energy than previous methods.[Beckman, 1971 #1355; Flocks, 1964 #1356; Perkins, 1973 #1358; Perkins, 1970 #1357; Zweng, 1970 #1361; Zweng, 1964 #1360] In 1973, Beckman and Sugar[Beckman, 1973 #1362] attempted unsuccessfully to use the neodymium laser in human irides.
The development of the continuous wave argon laser initiated the era of successful treatment of glaucoma. Successful argon laser iridotomy was achieved in rabbits by Khuri[Khuri, 1973 #1363] and in humans by Beckman and Sugar.[Beckman, 1973 #1362] Others soon reported successful iridotomy in eyes with angle-closure glaucoma.[Abraham, 1975 #1364; Pollack, 1976 #1365] Elimination of the difficulties associated with penetration of dark brown and blue irides led to virtually 100% success in penetration with this procedure and revolutionized the treatment of angle-closure glaucoma.[Ritch, 1983 #1366; Ritch, 1980 #1367; Ritch, 1982 #1368; Stetz, 1983 #1369; Hoskins, 1984 #1371; Pollack, 1984 #1370] By the early 1980s, argon laser iridotomy had replaced incisional surgical iridectomy as the procedure of choice for angle-closure glaucoma.[Abraham, 1977 #1378; Go, 1984 #1379; Harrad, 1985 #1380; Kramer, 1984 #661; Mishima, 1985 #1381; Podos, 1979 #1423; Pollack, 1980 #1424; Pollack,
1984 #1370; Quigley, 1979 #866; Ritch, 1979 #1050; Ritch, 1981 #686; Ritch, 1980 #1367; Ritch, 1989 #1427; Robin, 1982 #1429; Schwartz, 1978 #1445; Schwartz, 1979 #1444; Yamamoto, 1985 #1466; Yassur, 1979 #1467]
Many clinicians now use the neodymium:YAG (Nd:YAG) laser because of the relative simplicity of the procedure compared to the more subtle techniques necessary to produce an iridotomy with the argon laser.[Klapper, 1984 #1372; Latina, 1984 #1373; Moster, 1986 #1374; Schwartz, 1986 #1375; Tomey, 1987 #1376; Wishart, 1986 #1377] However, complications, particularly hyphema and inflammation, are more common and severe.
DIFFERENTIAL DIAGNOSIS OF ANGLE-CLOSURE GLAUCOMA
Determination of the specific pathophysiologic mechanism responsible for the angle closure is crucial in arriving at an accurate diagnosis and in planning appropriate therapy. It is not just differentiation of angle-closure from open-angle glaucoma that is important, but accuracy of diagnosis within the group of glaucomas characterized by angle-closure.
Angle-closure glaucoma is an anatomic disorder comprising a final common pathway of iris apposition to the trabecular meshwork resulting from various abnormal relationships of anterior segment structures. These in turn result from one or more abnormalities in the relative or absolute sizes or positions of anterior segment structures or posterior segment forces which alter anterior segment anatomy.[Ritch, 1995 #9836]
Angle-closure results from blockage of the meshwork by the iris, but the forces causing this blockage may be viewed as originating at four successive anatomic levels: the iris (pupillary block), the ciliary body (plateau iris), the lens (phacomorphic glaucoma), and posterior to the lens (malignant glaucoma).[Ritch, 1995 #9836] The more posterior the level at which the angle-closure occurs, the more complex is diagnosis and treatment, since each level may have a component of the mechanism peculiar to each of the levels preceding it. Understanding these mechanisms makes appropriate treatment in any particular case an exercise in deductive logic.
Indentation gonioscopy provides the advantage of a dynamic view of the anterior chamber angle and is mandatory when evaluating an angle for the presence of peripheral anterior synechiae (PAS) (Figures 1, 2).[Forbes, 1966 #140] When attempting to determine whether or not a narrow angle is occludable, gonioscopy should always be performed in a completely darkened room using the smallest square of slit-lamp illumination possible which will enable a view of the angle. The difference in the angle in light and dark conditions may be much greater than expected and can be demonstrated by ultrasound biomicroscopy (UBM) (Figure 3). UBM is extremely useful for explaining the nature of angle-closure and the rationale of treatment to patients who may be confused between open-angle and angle-closure glaucomas and different types of laser surgery.
Pupillary Block (Aqueous pressure)
In pupillary block, aqueous humor flow from the posterior chamber to the anterior chamber is limited by resistance to aqueous flow through the pupil by iridolenticular contact. This creates a relative pressure gradient between the two chambers, and forces the iris anteriorly, causing anterior iris bowing, narrowing of the angle, and acute or chronic angle-closure glaucoma (Figure 4). During indentation gonioscopy, pressure on the cornea forces aqueous into the angle, widening it to permit viewing over the iris convexity. Since only aqueous in the posterior chamber offers resistance, the angle opens easily (Figure 5). The anterior segment structures and their anatomic relationships appear otherwise normal.
Pupillary block may be either relative or absolute. Relative pupillary block typically occurs in hyperopic eyes, which have a shorter than average axial length, shallower anterior chamber, thicker lens, more anterior lens position, and smaller radius of corneal curvature.[Lowe, 1977 #106; Delmarcelle, 1976 #110; Tomlinson, 1973 #111; Lowe, 1973 #100; Lee, 1984 #114] In absolute pupillary block, posterior synechiae between the iris and lens are responsible. When pupillary block develops, the iris assumes a bombé configuration, creating an angle which is narrow throughout its approach (Figure 6). Relative pupillary block is the underlies approximately 90% angle-closure. The rest have one or more mechanisms other than or in addition to pupillary block. Some can be worsened by miotic therapy, particularly in patients with intumescent or anteriorly subluxated lenses or malignant glaucoma.
Laser iridotomy eliminates the pressure differential between the anterior and posterior chambers and relieves the iris convexity. This results in several changes in anterior segment anatomy. The iris assumes a flat or planar configuration and the iridocorneal angle widens. The region of iridolenticular contact actually increases, as aqueous flows through the iridectomy rather than the pupillary space (Figure 7).[Caronia, 1996 #10128]
Plateau Iris (Ciliary Body Pressure)
A large or anteriorly positioned ciliary body can maintain the iris root in proximity to the trabecular meshwork, creating a configuration known as plateau iris.[Tornquist, 1958 #195; Tornquist, 1958 #195; Pavlin, 1992 #240; Ritch, 1992 #1046; Wand, 1993 #3212; Ritch, 1992 #1046; Pavlin, 1992 #240] The anterior chamber is usually of medium depth and the iris surface slightly convex. On gonioscopy, the iris root angulates forward and then centrally. With indentation gonioscopy, the ciliary processes prevent posterior movement of the peripheral iris, resulting in a configuration in which the slit beam follows the curvature of the iris to its deepest point at the periphery of the lens where the ciliary processes begin, then rises again over the ciliary processes before dropping peripherally (S sign) (Figures 8,9). Greater force is needed to open the angle than in pupillary block because the ciliary processes must be displaced, and the angle does not open as widely.
Plateau iris syndrome refers to the development of angle-closure, either spontaneously or after pupillary dilation, in an eye with plateau iris configuration despite the presence of a patent iridectomy or iridotomy. Acute angle-closure glaucoma may develop.[Godel, 1968 #196; Lowe, 1968 #197; Lowe, 1981 #198; Wand, 1977 #199] The extent, or the "height" to which the plateau rises, determines whether or not the angle will close completely with a rise in IOP (complete plateau iris syndrome) or only partially without a rise in IOP (incomplete plateau iris syndrome).[Lowe, 1989 #2841] The angle can narrow further with age due to enlargement of the lens, so that an angle with plateau configuration which does not close after iridotomy may do so some years later. Periodic gonioscopy is required. Argon laser peripheral iridoplasty (ALPI) is the definitive treatment for plateau iris.[Ritch, 1992 #1501]
Treatment must be targeted at the cause of angle-closure, in this case the ciliary body and iris root. If pupillary block is either not a component mechanism of the angle-closure or has been eliminated by iridotomy, it is necessary to find a way to eliminate the physical blockage of the angle. This is accomplished by ALPI, which compresses the iris root and creates a space where none was before.
Phacomorphic Glaucoma (Lens Pressure)
Lens swelling may convert a medium depth anterior chamber into a very shallow one and precipitate acute angle-closure glaucoma (phacomorphic glaucoma) from the lens forcing the iris and ciliary body anteriorly. Paradoxical reactions to pilocarpine treatment, which increases axial lens thickness and causes anterior lens movement, further shallowing the anterior chamber, are common.[Bleiman, 1979 #653; Abramson, 1973 #89; Abramson, 1974 #87; Gorin, 1966 #625; Rieser, 1972 #626] ALPI is effective in breaking attacks of phacomorphic angle-closure.[Ritch, 1982 #627]
The eye may be severely inflamed, as these patients are often referred after being treated unsuccessfully for a few days. Treatment must be oriented at the level of the lens. Lens removal is indicated for intumescent cataracts, but is prone to complications if performed during an acute angle-closure attack. Breaking the attack with ALPI allows two to three weeks for the inflammation and cornea to clear, permitting cataract extraction under conditions much closer to ideal.[Ritch, 1982 #627] Any element of pupillary block is treated as soon as possible (usually within two to three days) after breaking the attack.
In anterior lens subluxation due to trauma or such hereditary disorders as Weill-Marchesani syndrome, ALPI is less successful because the pressure of the lens against the iris continues, with or without an iridotomy, as long as the underlying cause is present. Cycloplegics are useful if the zonules are intact, but these may not always be so.[Ritch, 1992 #1673] A more complete discussion of this subject can be found elsewhere.[Liebmann, 1996 #10165; Ritch, 1996 #10166] If not treated in time, forward lens movement can lead to malignant glaucoma.
Malignant Glaucoma (Posterior segment pressure)
Also termed ciliary block or posterior aqueous misdirection, angle-closure caused by forces posterior to the lens which push the lens-iris diaphragm forward presents the greatest diagnostic and treatment challenge of the angle-closure glaucomas. Analogous to pupillary block, in which the angle is occluded by iris because of a pressure differential between the posterior and anterior chambers, in ciliary block, a pressure differential is created between the vitreous and aqueous compartments by aqueous misdirection into the vitreous (Figure 10).
Swelling or anterior rotation of the ciliary body with forward rotation of the lens-iris diaphragm and relaxation of the zonular apparatus causes anterior lens displacement. Ultrasound biomicroscopy often reveals a shallow supraciliary detachment not evident on routine B-scan examination (Figures 11, 12). This effusion appears to be the cause of the anterior rotation of the ciliary body and the forward movement of the lens-iris diaphragm. This, combined with aqueous misdirection into the vitreous, increases vitreous pressure, pushing the lens-iris diaphragm forward and causing angle-closure by physically pushing the iris against the trabecular meshwork in a manner similar to that in phacomorphic glaucoma.[Phelps, 1974 #643]
The effusions in many of these conditions, such as angle closure after PRP or scleral buckling, is self-limited, but treatment is indicated to prevent PAS formation and to lower IOP. A component of pupillary block is often present and the opposite angle often narrow, and if the cornea is clear, laser iridotomy can be performed. If appositional closure remains after iridotomy or if the cornea is not clear, ALPI again is almost always successful at opening the angle.
II. LASER IRIDOTOMY
A. Indications
1. Acute angle-closure glaucoma
Laser iridotomy is the procedure of choice for all angle-closure glaucomas with a component of pupillary block. All eyes with acute angle-closure glaucoma require laser iridotomy. Therapy can be assumed successful only when the angle can be determined to be open gonioscopically, as transient lowering of IOP may occur with medical therapy. Ideally, iridotomy should be performed after the acute attack has been terminated and the eye no longer inflamed. If this is not possible but the iris can be adequately visualized, iridotomy can be attempted, preferably with the argon laser because of the greater chance of iris bleeding with the Nd:YAG laser.[Fleck, 1991 #1476] Alternatively, pretreatment with the argon laser may allow safe application of the Nd:YAG laser with minimal bleeding. If an argon laser is not available and the Nd:YAG is to be used, an attempt should be made to perforate the iris with a single application, as bleeding at the iridotomy may preclude a second laser
application at that site. Acute angle-closure glaucoma which is unresponsive to medical treatment, or in which iridotomy is not possible due to hazy media, may be successfully aborted with ALPI (see below).[Ritch, 1982 #627; Ritch, 1989 #1427; Shin, 1982 #663]
Eyes with phacomorphic glaucoma usually have some element of pupillary block, but the response to treatment with miotics is often paradoxical, resulting in worsening of the attack.[Kramer, 1984 #661] Ciliary muscle contraction further loosens the zonules and causes lens thickening and anterior lens movement, further narrowing the angle. ALPI will almost always break the attack.[Tomey, 1992 #1510; Ritch, 1982 #627; Ritch, 1992 #1501]
Chronic Angle-closure Glaucoma
Eyes with chronic appositional closure with or without PAS are at risk for progressive synechial closure, trabecular damage, elevated IOP, and acute angle-closure. Iridotomy can eliminate the progression of PAS in eyes with chronic angle-closure caused by pupillary block. Even if the angle structures cannot be visualized by indentation gonioscopy prior to treatment (which may occur when IOP is over 40 mmHg), areas of functional meshwork may become apparent after iridotomy, particularly when there is "hamstringing" of the iris between PAS. In essence, all eyes with angle-closure should be given the benefit of iridotomy before filtration surgery is considered.
The effect of iridotomy on IOP control depends upon the degree of trabecular dysfunction. In eyes with minimal damage, iridotomy alone may reduce or control IOP. Failure of medications to control IOP prior to iridotomy does not necessarily mean that this will be so afterward. Quigley et al[Quigley, 1981 #1426] found reduced IOP in 44% of eyes with chronic angle-closure. After elimination of pupillary block by iridotomy, repeat gonioscopy may permit a more complete evaluation and assessment of the extent of trabecular injury and synechial closure.[Gieser, 1984 #685; Pollack, 1980 #1424; Ritch, 1980 #1367; Rivera, 1985 #265]
Aphakic or Pseudophakic Pupillary Block
Aphakic and pseudophakic pupillary block may be relieved by laser iridotomy.[Anderson, 1975 #1231; Cinotti, 1986 #1390; Forman, 1987 #1397; Patti, 1975 #1422; Samples, 1987 #1438; Werner, 1977 #1460] Loculation of pockets of both aqueous and vitreous may be present posterior to the iris, due to iridovitreal, iridocapsular, or iridolenticular adhesions. An iridotomy made over an area of vitreous-iris adhesion or apposition will not relieve the pupillary block[Anderson, 1975 #1231] Multiple iridotomies may be required before a pocket of aqueous humor is located and the block relieved.[Anderson, 1975 #1231; Ritch, 1980 #1367; Shrader, 1984 #1450; Melamed, 1988 #1490] In situations in which more than one loculated area is present, at least one iridotomy will be required for each area of loculation. Iridotomy helps to rule out pupillary block in cases of suspected malignant glaucoma, which requires disruption of the anterior hyaloid face or vitrectomy.[Epstein, 1984 #1395;
Shrader, 1984 #1450]
Prophylactic Iridotomy
With rare exceptions, prophylactic iridotomy should be performed in the fellow eye of a patient with either acute or chronic angle-closure glaucoma. Given similar refractive errors and globe size, the fellow eye of a high proportion of such individuals will eventually develop angle-closure. Angle-closure associated with an intumescent or anteriorly subluxated lens may present with an open, nonoccludable angle in the fellow eye. This may also occur in anisometropia, with angle-closure developing in the more hyperopic eye. Eyes with normal IOP and spontaneous appositional closure of at least one full quadrant on darkroom gonioscopy should also have prophylactic iridotomy.
In a retrospective study of 50 eyes treated with laser iridotomy or surgical iridectomy and 64 eyes treated medically to assess the long-term outcome of surgical and medical treatment of narrow angles, eyes receiving iridotomy or iridectomy showed a greater number of improved anterior chamber configurations (74% vs. 28%), had a lower incidence of PAS (2% vs. 10%) and required fewer antiglaucoma medications.[Schwartz, 1992 #1543] The overall percentage of eyes with increased IOP, decreased visual acuity, and abnormal visual fields were similar in the two groups.
Malignant Glaucoma
When acute angle-closure occurs on the basis of malignant glaucoma, medical treatment and/or iridotomy are usually insufficient to relieve the glaucoma. ALPI can open the angle, at least temporarily, and lower IOP. Prophylactic iridotomy usually protects the fellow eye against both acute angle-closure glaucoma and malignant glaucoma which could be triggered by opening and decompressing the globe. Pilocarpine, which increases lens thickness and shallows the anterior chamber, may trigger an episode of malignant glaucoma.[Cashwell, 1992 #1517; Merritt, 1977 #639]
To facilitate argon laser trabeculoplasty (ALT)
ALT may be difficult to perform in open but anatomically narrow angles. In these cases, iridotomy will facilitate the trabeculoplasty. If the angle is narrow on the basis of plateau iris, ALPI is a better alternative for improving visualization of the angle structures.
Nanophthalmos
Nanophthalmos, characterized by high hyperopia, short axial length, small corneal diameter, thick sclera, and narrow angles,[O'Grady, 1971 #8231] represents one end a spectrum of disease, and many hyperopic eyes have crowded anterior segments. Patients with nanophthalmos are anatomically predisposed to angle-closure glaucoma due to anterior chamber crowding. Angle-closure glaucoma usually appears between the ages of 20 and 50 years. Laser iridotomy is usually unsuccessful or only temporarily successful. Bilateral nonrhegmatogenous retinal detachments have been described following laser iridotomy[Karjalainen, 1986 #1408] and may be attributable to worsening of preexisting retinal or choroidal disease.[Singh, 1987 #1451]
Pigment dispersion syndrome
Laser iridotomy eliminates the iris concavity often found in pigment dispersion syndrome.[Potash, 1994 #1073; Pavlin, 1994 #3198; Lagreze, 1995 #10130] The concave iris configuration is due to reverse pupillary block, in which aqueous passing from the posterior to the anterior chamber cannot equilibrate because of extensive iridolenticular contact. The sudden increase of aqueous volume into the anterior chamber pushes the iris back against the zonular bundles. Iridotomy provides an additional pathway for aqueous equilibration between the chambers (Figure 13).
Contraindications
Iridotomy is contraindicated when angle-closure is caused by contraction of the iris against the trabecular meshwork, such as in uveitis, neovascular glaucoma or iridocorneal endothelial syndrome. It should not be performed in eyes with corneal edema or opacification precluding a view of the iris, or a grade 2 or 3 flat anterior chamber.
Techniques of Laser Iridotomy
Preoperative Preparation
Contact lenses reduce saccades and extraneous eye movements that can interfere with accurate superimposition of burns, keep the lids separated, focus the beam, and minimize reflective loss of laser power, while the gonioscopy solution absorbs excess heat, decreasing the chance of corneal burns.[Abraham, 1981 #1382; L'Esperance, 1975 #1415; Pollack, 1980 #1424; Ritch, 1983 #1366] The Abraham lens consists of a fundus contact lens with a +66 diopter planoconvex lens button on its anterior surface. This provides magnification without loss of depth of focus and reduces the effective size of a 50 µm spot on the iris surface to approximately 30 µm, providing higher energy per unit area and permitting the procedure to be performed with a lower total energy. The beam is rapidly defocused posterior to the site of focus, decreasing potential injury to the posterior segment.[Bongard, 1985 #1386; Schirmer, 1983 #1440] The Wise lens is similar but has a+ 103 diopter button, allowing even
greater concentration of laser energy.[Wise, 1986 #1463]
Topical anesthesia virtually always suffices. If the pupil is not already maximally miotic, 2% or 4% pilocarpine should be administered to minimize iris stromal thickness. Perioperative apraclonidine decreases the magnitude and frequency of postlaser IOP spikes,[Hill, 1991 #1525; Krupin, 1992 #1526; Robin, 1989 #1528; Robin, 1987 #1432] for which patients with more extensive synechial closure or trabecular dysfunction are at higher risk. The greater the energy used, the greater the risk of postoperative IOP spike.
Iris variations in thickness, color, and number and size of crypts should be taken into account (Figure 14). It is usually easier to perform iridotomy in the base of an iris crypt, where the stroma is thinner. An arcus senilis should be avoided because the density of the arcus causes a drop in laser power across the cornea, and the arcus itself interferes with clear focusing of the beam. This is less of a problem with the Nd:YAG laser than with the argon laser. The beam should be perpendicular to the contact lens surface to maximize energy delivery. Since focus is critical to efficient laser energy delivery, all lenses should be clean. Medium brown irides are generally the easiest to penetrate with the argon laser, the energy of which is readily absorbed by the iris pigment. Light blue and dark brown irides are more difficult.[Ritch, 1979 #1050; Rivera, 1985 #265] Lighter irides are more easily penetrated with the Nd:YAG laser than are darker, thicker irides.
The iridotomy should be made peripherally between 11:00 and 1:00, where it will be covered by the upper lid, to minimize glare and diplopia. If the iridotomy is bisected by either the lid or the tear meniscus, the patient may be bothered by glare or a "white line" in the superior visual field.[Murphy, 1991 #1493] The beam should be aimed to avoid accidental foveal injury; performing the iridotomy nasally eliminates this possibility.
Types of argon laser burns
Various types of burns, including contraction, penetrating, punch, and cleanup burns, and their uses in particular circumstances have been fully described elsewhere.100 Low power, large spot size, and long duration contraction burns (500 µm spot size, 0.5 second duration, and 200 to 400 mW power) compact the stroma at the site of the burn and (1) increase the density of iris stroma to facilitate laser energy absorption in blue or light brown irides, (2) create a "hump" on which penetrating burns are placed, and (3) perform ALPI or pupilloplasty. One should begin with 200 mW in brown irides and 300 mW in light ones and adjust the power as necessary. If bubbles or pigment release occur, the power should be reduced. In very light irides, a 200 µm spot size may be more effective.
Penetrating burns are higher-power, small spot size (50 µm) burns designed to vaporize iris tissue and create an opening. In the late 1970s and early 1980s, burns of 0.1-0.2 sec duration and 1000-2000 mW power were common. These produce charring and penetration failure in darkly pigmented irides, while lower power, shorter duration burns are more successful at penetrating the surface layer of the iris and densely pigmented stroma.[Ritch, 1982 #1368] Burns of 0.01 or 0.02 sec duration were formerly termed punch burns. The optimal power is 600-1200 mW and varies depending on the duration of the burn and the consistency and pigmentation of the iris. In many eyes, the iris surface layer has denser pigment than the stroma. Charring is minimal or absent when punch burns are used.
In most blue, hazel and light brown irides, burns of 0.05 second duration, 50 µm spot size, and 600-800 mW power can be used after initial contraction burns. Failure of tissue to vaporize with each laser application implies that laser energy is being applied without effect. A second site may need to be chosen or a Nd:YAG laser employed.
Shorter duration (0.01 or 0.02 sec) burns are optimal for use in dark irides, particularly in black and Asian patients, to avoid charring at the base of the iridotomy site.[Ritch, 1982 #1368; Yamamoto, 1982 #1465; Mandelkorn, 1981 #1418; Mishima, 1985 #1381; Ritch, 1984 #5269; Ritch, 1982 #5270; Yamamoto, 1983 #5271] Once the surface layer of fibroblasts and melanocytes has been penetrated and the stroma is being chipped away, the duration can be increased to 0.05 sec. Posterior synechiae may occur less frequently with short duration burns.[Mishima, 1985 #1381]
After the stroma has been eliminated, cleanup burns (about 200 mW power, 100-200 µm spot size, and 0.2 sec duration) are used to remove residual iris pigment epithelium without dislodging more pigment into the opening. If shock waves due to high energy absorption are created, pigment from surrounding areas will often move into the opening (landsliding).
Linear Evaporation
This technique, originally described by Wise,[Wise, 1985 #1461; Wise, 1987 #5268] uses the radial orientation of the dilator muscle to enlarge the iridotomy. Punch burns are used to make a straight-line incision in the iris, perpendicular to the dilator muscle. The incision should be about 500 µm long, full-thickness throughout its length, and only as wide as a single row of laser burns. When the stroma is fully incised, the dilator muscle assists in separating the pigment epithelium, reducing the amount of pigment epithelium which must be lased and creating a larger opening.
Drumhead technique
In this approach, developed in the 1970s,[Pollack, 1980 #1424] 6-8 burns of 0.2 sec, 200 mW, and 200 µm are placed in a circle around the site selected for penetration to thin the iris stroma in the center of the ring and make it more taut. Penetrating burns are then applied in the center of the ring.
Helpful hints
Improvisation and flexibility in technique and choice of laser settings for different types of irides are the keys to success. The entire procedure may require anywhere from 1 to 300 burns. It should be remembered that 200 applications of 0.02 sec duration and 600 mW power equals 10 applications of 0.2 sec duration and 1200 mW power, the latter settings often requiring 100-200 burns to penetrate a dark iris.
For any iridotomy, the first burn often serves as an indicator for the ease of the procedure. The desired result from the first burn is the appearance of a small hole with a darker base and dispersion of a small amount of debris into the anterior chamber. Bubble formation indicates stromal vaporization. One then continues to deliver burns until the stroma has been penetrated.
In the absence of stromal pigmentation, bubble formation and pigment release may be minimal. One clue to the gradual deepening of the iridotomy is a gradual darkening of the base. An orange reflex at the time of beam impact, most commonly seen in irides with little stromal pigmentation, signifies that one is nearing the pigment epithelium.
When the pigment epithelium is reached, denser bursts of fine pigment appear in the anterior chamber. A cloud of pigment mixed with aqueous often slowly balloons into the anterior chamber, indicating passage of aqueous from the posterior chamber. Simultaneously, the iris stroma floats backward and the peripheral anterior chamber deepens. This can be quite marked in eyes with greater degrees of relative pupillary block. After penetration, the iridotomy may be enlarged and pigment removed with cleanup burns. At completion, the lens capsule should be visible through the opening. Gonioscopy should be performed to assure that the angle is open.
Transillumination through the pupil or the iridotomy is not a reliable indicator of success in light irides, since it is possible to destroy pigment epithelium without penetrating the stroma. Once this happens, the overlying stroma cannot be penetrated except with a Nd:YAG laser, and the surgeon may mistakenly assume that the procedure has been successful.
Neodymium:YAG Laser Iridotomy
The Nd:YAG laser creates a plasma of free ions and electrons at the site of optical breakdown. This photodisruption releases shock waves that mechanically cause tissue rupture, as opposed to the thermal effect of the argon laser.[Prum, 1991 #1499; Goldberg, 1987 #4641] Iris color and density are much less important than with argon laser iridotomy. By the mid 1980s, several series had been published describing the easily obtained, successful results of Nd:YAG laser iridotomy.[Haut, 1986 #5273; Albuquerque, 1987 #5274; Rockwood, 1984 #5275; Schrems, 1987 #5276; Wand, 1988 #5277; Moster, 1986 #1374]
One should begin with a single pulse at approximately 1.5 to 3 mJ to assess the response of both the patient and the iris to the laser application. An increase in energy to 4 to 6 mJ is often sufficient to create a patent iridotomy with one to three additional applications. We prefer a linear incision technique using lower power burns, on the order of 1 mJ,[Wise, 1987 #5268; Wise, 1987 #1462] and never to use the multiple pulse mode. The importance of precise focus on the anterior iris stroma cannot be overemphasized; maximal photodisruption is obtained and the possibility of lens injury minimized.[Fernandez-Bahamonde, 1991 #4636] Since the anterior lens surface is further from the iris in the periphery, the chance of accidental lens injury is reduced by choosing a peripheral location.
Other Wavelengths
Combining argon laser to thin the iris stroma and coagulate blood vessels followed by Nd:YAG completion has been advocated as an approach which takes advantage of the photothermal effects of the first and easier penetration achieved via photodisruption of the latter.[Ho, 1992 #1482; Damerow, 1989 #4642; Zborowski-Gutman, 1988 #4643; Singh, 1987 #1451] The risk of hemorrhage is also reduced.[Goins, 1990 #1480] Iridotomies may also be successfully created with combined dye and argon,[Hitchings, 1985 #1404] diode,[Emoto, 1992 #1475; Schuman, 1990 #1507] krypton,[Yassur, 1986 #5267] and picosecond[Frangie, 1992 #4637; Oram, 1995 #10127] lasers.
Postoperative Management
The eye should be irrigated to remove excess methylcellulose and a drop of prednisolone applied. An additional drop of apraclonidine can be administered. The patient should be reassured that the visual blur will dissipate. We often suggest that the patient relax for a short period of time and then return in 60 to 90 minutes for a postlaser pressure check. If the IOP is lower, which is often the case due to the previously administered pilocarpine and apraclonidine, the patient is discharged and instructed to return for follow-up from 1 day to 1 week, depending upon the severity of pre-existing damage and the complexity of the angle-closure mechanisms. The pupil can be dilated at that time if desired. Although the follow-up schedule needs to be individualized, all patients should be evaluated four to six weeks postoperatively to determine continued patency of the iridotomy. If a postoperative IOP rise occurs, oral hyperosmotics usually suffice to control it. Rarely,
paracentesis may be required.
Histopathology
Initial changes in the iris near the iridotomy site include edema, necrosis, loss of melanocytes, the presence of pigment-laden macrophages, and irregular clumps of granules on the pigment epithelial surface.[Pollack, 1980 #1424; Pollack, 1976 #1365; Rodrigues, 1978 #1435] Histopathologic examination of Nd:YAG laser iridotomies reveals circumscribed holes with limited tissue alteration at the margin, compared with more extensive early edema and tissue destruction after argon laser iridotomy.[Rodrigues, 1985 #1434] Pigment debris accumulates in the trabecular meshwork and decreases with time.[Robin, 1982 #1433] The pigment granules initially are located in the extracellular and intracellular spaces and are phagocytosed by the trabecular cells. The pigment becomes more concentrated in the juxtacanalicular meshwork and is progressively absorbed. Histopathology of Nd:YAG laser iridotomy, obtained at the time of cataract surgery 3 to 5 years later, reveals the edges to contain
loosely arranged melanocytes, fibrocytes and vessels without evidence of pigment proliferation or scarring.[Tetsumoto, 1992 #1509] Inflammatory changes in the meshwork have been noted histologically after persistent pressure elevation following laser iridotomy.[Greenidge, 1984 #804] Any increase in tonographic outflow facility after iridotomy is probably related to relief of pupillary block and reversal of appositional angle-closure.[Pollack, 1980 #1424]
Postlaser iris configuration and anterior chamber depth
Increased peripheral chamber depth has been shown ultrasonographically.[Schrems, 1990 #4639] Central anterior chamber depth is unaffected.[Jacobs, 1979 #133] This has been confirmed with Scheimpflug photography,[Morsman, 1994 #5278] which also shows a decrease in iris convexity.[Jin, 1990 #1484] Iridolenticular contact increases following laser iridotomy.[Caronia, 1996 #10128] Any apparent deepening of the central anterior chamber may be the result of the postlaser use of cycloplegia and discontinuation of miotics and their respective effects on lens position.
Complications
Corneal Damage
Corneal edema may prevent achieving a patent iridotomy with either the argon or the Nd:YAG laser. Scattering of the beam diffuses the laser power and precise focusing on the iris may be impossible. Greater energy is usually necessary and may cause corneal damage. If the angle is closed, ALPI can usually open it and lower IOP, buying time until the cornea can clear. If ALPI has been performed, but corneal edema is persistent, pupilloplasty to peak the pupil may eliminate pupillary block.
The argon laser can cause epithelial and endothelial thermal burns. Both were far more common when settings of 0.1 and 0.2 second were used. These rarely occur with the use of lower energy burns. Epithelial coagulation and whitening are transient, but may interfere with the delivery of laser energy and make the creation of a patent iridotomy difficult. If this occurs, an attempt can be made to angle the beam around the burn to complete the iridotomy.[Cooper, 1981 #1392] It may be necessary to choose another location for the iridotomy or use a Nd:YAG laser. Stromal edema and striate keratopathy may also occur. If the anterior chamber is extremely shallow, corneal endothelial injury may develop rapidly. This may be circumvented by using contraction burns to deepen the chamber before the placement of punch burns or penetrating burns. When the anterior chamber is extremely shallow, the power should be reduced and applications not performed too rapidly.
Endothelial burns are generally dense white with sharp margins. They require more time for resolution and may result in focal endothelial cell loss. Although endothelial cell loss following argon laser iridotomy has not been statistically significant during follow-up periods of up to 1 year,[Wishart, 1986 #1464; Panek, 1988 #1496; Hirst, 1982 #1403; Smith, 1984 #1452; Thoming, 1987 #1456] an increase in mean cell size and cell loss associated with the use of greater laser powers has been reported.[Hong, 1983 #798] Although endothelial cell number after Nd:YAG iridotomy has been reported to be unchanged,[Schrems, 1986 #1441; Panek, 1991 #1497] focal loss occurs when photodisruption takes place less than 1 mm from the endothelium and at the site of treatment.[Panek, 1991 #1497; Meyer, 1984 #1421] The area of focal loss is reduced with the use of an Abraham lens.[Power, 1992 #1498] Damage to Descemet's membrane occurs when this distance is reduced to 0.1 mm. Progressive corneal
edema requiring penetrating keratoplasty has been reported following Nd:YAG[Wilhelmus, 1992 #1514] or argon[Jeng, 1991 #1483; Zabel, 1991 #1515; Kalnins, 1989 #4645; Schwartz, 1988 #1508] therapy. Risk factors appear to include preexisting guttata and excessive laser energy.[Jeng, 1991 #1483; Zabel, 1991 #1515]
Intraocular Pressure Elevations
Prior to apraclonidine, transient postlaser pressure spikes were common. A rise greater than 6 mmHg occurred in up to 40% of patients and to over 30 mmHg in as many as 30%.[Krupin, 1985 #1413; Pollack, 1984 #1425; Robin, 1984 #1430; Schwartz, 1986 #1375] Approximately two-thirds of patients had a maximal elevation in the first hour and one-third in the second.[Moster, 1986 #1374; Pollack, 1984 #1425] Rapid elevation to high levels occurred immediately after both argon and Nd:YAG iridotomies.[Henry, 1986 #1401; Krupin, 1985 #1413; Moster, 1986 #1374; Robin, 1986 #1428; Schrems, 1984 #1442; Taniguchi, 1987 #1454; Yamamoto, 1982 #1465] Perioperative apraclonidine decreases the duration and magnitude of the rise and most IOP elevations are mild and easily controlled.[Robin, 1987 #1432; Robin, 1989 #1528; Robin, 1987 #1432; Kitazawa, 1989 #1486; Hong, 1991 #4647; Brown, 1988 #706]
No significant difference in postoperative pressure rises has been found between the two types of lasers.[Robin, 1984 #1430] The elevation may be related to the amount of energy used, the degree of pigment dispersion, and the preoperative outflow facility. Eyes in which iridotomies are performed prophylactically may have a lower incidence of postoperative IOP spikes.[Yassur, 1979 #1467] Pre- and/or postlaser treatment with miotics, beta-blocking agents, carbonic anhydrase inhibitors, or oral hyperosmotic agents has also been reported to reduce the severity of the rise.[Brown, 1985 #1257; Schrems, 1984 #1442; Liu, 1987 #1416; Liu, 1987 #1416; Hsieh, 1992 #4646]
Closure of the iridotomy Site
Closure of a previously patent iridotomy may be immediate or delayed. Early closure is caused by occlusion of the opening by circulating debris or landsliding of the pigment epithelium surrounding the iridotomy site [Brainard, 1982 #1387; Ritch, 1980 #1367] and is typically visible immediately following the procedure or at the time of the first postoperative visit.
Delayed closure is usually caused by localized pigment proliferation occluding the opening. Pigment proliferation is more prominent after argon laser iridotomy[Ritch, 1980 #1367; Del Priore, 1988 #1472] and usually occurs within the first 6 to 12 weeks. As many as one third of patients have been reported to require retreatment. The iris opening after Nd:YAG laser iridotomy is more irregular, with less pigment dispersion, but retreatment may be necessary in about 9% of patients.[Schwartz, 1986 #1375] Closure is extremely common in patients with uveitis after either type of laser. Other causes of late failure include the development of a transparent, thin fibrous membrane occluding the opening and regeneration of iris pigment epithelium from the margins of the iridotomy. This characteristically grows in evenly from the margins of the iridotomy toward the center and does not come forward to occlude the portion of the opening through the stroma. Functional closure may occur with
the formation of posterior synechiae between the iridotomy site and the lens. Retreatment to open the iridotomy is easy. Argon laser iridotomies that repeatedly close may remain open after Nd:YAG treatment.[Gilbert, 1984 #1523]
Other complications
Blurred Vision: Patients routinely experience transient postlaser blurring of vision. Patients should be informed preoperatively that when the argon laser is used, retinal pigment bleaching limits vision for 20-30 minutes and makes everything appear red. Other factors which contribute to blurring include the use of methylcellulose, pigment dispersion, anterior segment inflammation, residual pilocarpine effect, or hyphema when the Nd:YAG laser has been used.
Pupillary Abnormalities: Slight contraction of the iris toward the site of iridotomy is common, generally minor, transient, and does not produce visual complaints. It is more prominent with the argon laser than with the Nd:YAG laser. The extent of the peaking is greater the closer the iridotomy is to the pupil, the lighter the iris, and the greater the total energy used.
Diplopia and Glare: These are uncommon given the small size of most iridotomies, but may develop or worsen if the iridotomy enlarges over time.[Sachs, 1984 #1437] Diplopia is more common if the iridotomy is placed nasally or temporally, but may occur anywhere if it is not covered by the upper lid. The sensation of a horizontal line in the upper visual field, occasionally accompanied by glare, is common. It occurs when the iridotomy is partially covered by the lid margin and is relieved when completely covered or completely exposed.[Murphy, 1991 #1493] There is also a "shutter effect" created by the lid crossing the iridotomy site during blinking. Patients often no longer notice it after a few months. Tinted soft contact lenses to ameliorate diplopia have been described.[Kublin, 1987 #1414] Opaque contact lenses to cover the iridotomy site may be used to reduce the amount of stray light entering through it.[Fresco, 1992 #4638]
Inflammation: Postlaser anterior segment inflammation is typical, usually mild, and ceases within several days. Breakdown of the blood-aqueous barrier has been demonstrated with both the argon and Nd:YAG lasers.[Sanders, 1983 #1439; Schrems, 1984 #1443] Topical corticosteroids are routinely prescribed for a few days.
Posterior synechiae may occur between the pupil and the lens or the iridotomy site and the lens.[Lederer, 1989 #1487] Their formation may be less common after Nd:YAG laser iridotomy,[Moster, 1986 #1374] can be minimized by postoperative topical steroids, minimizing the total energy applied, and by dilating the pupil at the time of the first postoperative visit if the iridotomy is patent and the angle is adequately open.
Hemorrhage: Bleeding is rare with the argon laser because the iris tissue undergoes thermal coagulation. However, hyphema may occur[Hodes, 1982 #1405] and may even occur days after the iridotomy, accompanied by increased IOP.[Rubin, 1984 #1436] Nd:YAG photodisruption does not coagulate iris vessels, and a small hemorrhage at the iridotomy site may occur in up to 50% of patients.[Dragon, 1985 #1394; McAllister, 1984 #1419; Pollack, 1984 #1425] Bleeding can occasionally be more substantial.[Gilbert, 1984 #1523] Gentle pressure on the eye with the contact lens may help control the bleeding. The argon laser may be used to coagulate bleeding vessels or may be used before the Nd:YAG laser to coagulate the iris vessels in the location of the anticipated Nd:YAG iridotomy. Iridotomy in eyes with rubeosis or uveitis should be performed with the argon laser.
Lens Opacities: Focal, nonprogressive, anterior subcapsular opacities may occur after both argon and Nd:YAG iridotomy in up to 45% of eyes.[Robin, 1984 #1430; Schwartz, 1986 #1375] However, no increased incidence of visual impairment from cataracts in patients having had laser iridotomy compared to the general population has been presented. The possibility that the permanently altered aqueous flow pattern may adversely affect lens physiology has not been either proven or disproven.
Although rare cases of capsular rupture with Nd:YAG iridotomy have been described,[Berger, 1989 #1469] the earlier widespread fear of acute onset of cataract after Nd:YAG iridotomy has not been substantiated. Limiting the use of the Nd:YAG laser to single burst mode, performing the iridotomy peripherally, and focusing on the anterior iris stroma minimize the chance of lens damage. These localized lens changes do not affect visual acuity. Small ruptures of the anterior lens capsule after Nd:YAG iridotomy have been documented histopathologically in patients undergoing subsequent intracapsular cataract extraction.[Welch, 1986 #1459] Animal studies suggest that fibrous proliferation covers the small anterior capsular breaks.[Gaasterland, 1985 #1398] Pitting of the anterior lens capsule by the Nd:YAG laser also occurs.[Welch, 1986 #1459]
Retinal Damage: The possibility of photocoagulation of the peripheral retina between the equator and the ora serrata, which usually occurs when an opening is being enlarged,[Quigley, 1981 #1426; Watts, 1971 #1458] is greatly reduced by the use of a contact lens.[Bongard, 1985 #1386; Wise, 1986 #1463] Inadvertent foveal photocoagulation has been reported,[Berger, 1984 #1385] and proper positioning of the laser beam is essential. Choroidal and retinal detachment[Corriveau, 1986 #1393] and nonrhegmatogenous retinal detachment in nanophthalmic eyes[Karjalainen, 1986 #1408] have also been reported. Microperforations of the retina may occur with the Nd:YAG laser if the beam is inadvertently focused to within 2 to 3 mm of the retina.[Jampol, 1983 #1407]
Miscellaneous complications: Sterile hypopyon,[Cooper, 1981 #1392; Shin, 1984 #1449; Cohen, 1984 #1391] cystoid macular edema,[Choplin, 1983 #1389] unexplained loss of central visual acuity,[Balkan, 1982 #1383] lens capsule rupture,[Fernandez-Bahamonde, 1991 #4636] pupillary pseudomembranes,[Geyer, 1991 #1479] phacoanaphylactic endophthalmitis,[Margo, 1992 #4648] and malignant (aqueous misdirection) glaucoma[Go, 1981 #1399; Aminlari, 1993 #1516; Cashwell, 1992 #1517; Brooks, 1989 #1470; Fourman, 1992 #1519; Robinson, 1990 #948; Geyer, 1990 #1520; Hodes, 1992 #4649] have been reported.
ARGON LASER PERIPHERAL IRIDOPLASTY (ALPI)
This is a simple and effective means of opening an appositionally closed angle in situations in which laser iridotomy either cannot be performed or does not physically eliminate appositional angle-closure because mechanisms other than pupillary block are present. Contraction burns (long duration, low power, and large spot size) placed in the extreme iris periphery withdraw the iris stroma from the angle and compress it, mechanically opening angle.[York, 1984 #4716; Ritch, 1982 #627; Ritch, 1983 #1366; Ritch, 1989 #1427; Ritch, 1992 #1501] ALPI is highly successful in reversing acute angle-closure glaucoma when medical treatment fails.[Ritch, 1982 #627; Lim, 1993 #4651] A technique for direct treatment of 360° of the peripheral iris through a gonioscopy lens, termed gonioplasty, served as the conceptual basis for the modern procedure.[Kimbrough, 1979 #1412] Although ALPI is simple to perform, important aspects of technique must be followed for a successful result.
Approach to Acute Angle-closure Glaucoma
Copious miotic treatment was, and still is, common in the treatment of acute angle-closure glaucoma. This, however, is undesirable for several reasons. When IOP is over 60 mmHg, the pupil becomes unresponsive to miotics because of ischemia and paralysis of the iris sphincter. Pilocarpine may paradoxically worsen the block.[Gorin, 1966 #625; Mapstone, 1974 #128; Rieser, 1972 #626; Ritch, 1982 #627] Miotics cause forward motion of the lens-iris diaphragm, and overtreatment can exacerbate acute angle-closure when it is due to block at the level of or behind the lens. The following is our approach to acute angle-closure glaucoma:[Kramer, 1984 #661]
1. Examine the affected eye and fellow eye, particularly noting central and peripheral anterior chamber depth, the shape of the peripheral iris, and the appearance on indentation gonioscopy.
2. Administer an oral hyperosmotic agent and, if desired, aqueous suppressants.
3. Place the patient supine. This permits the lens to fall backward to whatever extent possible when the hyperosmotic shrinks the vitreous. Remember that the vitreous volume is reduced only about 3%, but this 0.12 cc equals twice the volume of the posterior chamber and half the volume of the anterior chamber.
4. Reassess ocular findings after one hour. IOP is usually decreased, but the angle remains appositionally closed. One drop of 4% pilocarpine is given and the patient reexamined 30 minutes later.
a. If IOP is reduced and the angle is open, pupillary block or plateau iris or both are responsible for the angle-closure, and the patient may be treated medically with topical low-dose pilocarpine, beta-blockers and steroids until the eye quiets and laser iridotomy performed.
b. If IOP is unchanged or elevated and the angle remains closed, level 3 or 4 block should be suspected, further pilocarpine withheld, and the attack broken by ALPI.[Ritch, 1982 #627; Ritch, 1989 #662; Shin, 1982 #663]
We have performed ALPI in nearly 100 attacks of angle-closure glaucoma unresponsive to medical therapy, even after several days. All but one eye, which had total synechial closure, responded with at least transient normalization of IOP and opening of the angle. ALPI does not eliminate pupillary block and is not a substitute for laser iridotomy, which must be performed as soon as the eye is quiet. However, even in eyes with extensive synechial closure, IOP is lowered sufficiently for a few days for the inflammation to resolve. The alternative of prolonging a paradoxical reaction to medical therapy for several days seriously increases the possibility of irreversible damage to the iris, lens, cornea, trabecular meshwork, and optic nerve.
Up to one-third of angles without PAS remain narrow after iridotomy, and approximately half of these are capable of closure with mydriasis.[Lowe, 1964 #665] Continued appositional angle-closure in the presence of a patent iridotomy is an indication for ALPI.[Ritch, 1989 #1427; Ritch, 1992 #1501] If extensive PAS are present after ALPI, goniosynechialysis may be performed. This procedure is successful if the PAS have been present for less than one year.[Campbell, 1984 #670] Promising results have been reported in both phakic and pseudophakic eyes.[Ando, 1990 #1923; Nagata, 1985 #951; Tanihara, 1992 #2808] It is effective both alone and in conjunction with other surgical procedures.[Shingleton, 1990 #960] ALPI can be used postoperatively to further flatten the peripheral iris and prevent synechial reattachment.[Tanihara, 1991 #2807]
INDICATIONS FOR ALPI
Medically Unbreakable Attacks of Angle-closure Glaucoma
An attack of angle-closure glaucoma that is unresponsive to medical therapy outlined above and in which corneal edema, a shallow anterior chamber, or marked inflammation precludes laser iridotomy, or which is unresponsive to successful iridotomy, may be broken with ALPI.[Ritch, 1982 #627; Lim, 1993 #4651; Matai, 1987 #4650; Chew, 1991 #10148]
Circumferential treatment of the iris opens the angle in those areas in which there are no PAS. All published series have reported virtually 100% success. In a prospective study of 10 eyes with medically unbreakable attacks of 2-5 days duration, mean prelaser IOP was 54.9 mmHg and 2-4 hours postlaser was 18.9 mmHg.[Chew, 1991 #10148] Even when extensive PAS are present, the IOP is usually normalized within an hour or two, perhaps because of associated secretory hypotony. The effect lasts sufficiently long for the cornea and anterior chamber to clear so that, iridotomy can be performed. In cases in which an intumescent lens is responsible for the angle-closure attack, cataract extraction can be postponed until the intraocular inflammation has sufficiently resolved.
Plateau Iris Syndrome
In this condition, discussed above, the angle remains appositionally closed or occludable following laser iridotomy because of abnormally anteriorly positioned ciliary processes.[Pavlin, 1992 #240; Ritch, 1992 #1046]
Angle-Closure Related to Size or Position of the Lens
Angle-closure caused by an enlarged lens or pressure posterior to the lens (malignant glaucoma) is not often responsive to iridotomy, although iridotomy should be performed to eliminate any component of pupillary block. Appositional closure remaining after iridotomy can be partially or entirely eliminated by ALPI.[York, 1984 #4716; Ritch, 1989 #1427; Burton, 1988 #1471; Koster, 1990 #1930] After the angle has been opened and IOP reduced, cycloplegics may be given cautiously to ascertain the mechanism of the angle-closure.
Adjunct to Laser Trabeculoplasty
If a narrow but open angle results from plateau iris or angle-crowding, ALPI can retract the iris away from the trabecular meshwork.[Ritch, 1983 #1366]
Retinopathy of prematurity
Angle-closure in young children with retinopathy of prematurity occurs due to forward shifting of the lens-iris diaphragm.[Cohen, 1964 #8926; Hittner, 1979 #1894; Pollard, 1980 #5292; McCormick, 1971 #1898; Laws, 1994 #8928; Kushner, 1982 #1057] These children do not respond to iridotomy. In young adults with this condition, there appears to be a superimposed element of pupillary block, and iridotomy may be successful.[Ueda, 1988 #8927; Smith, 1984 #1899]
Nanophthalmos
Flattening of the peripheral iris by argon laser was first reported in 1979 by Kimbrough et al.[Kimbrough, 1979 #1412] Combined iridotomy and ALPI often brings the angle-closure under control.[Jin, 1990 #2759] Uveal effusions have been reported after both laser iridotomy[Karjalainen, 1986 #1408] and ALT.[Good, 1988 #2742] The risks of surgical intervention include malignant glaucoma, expulsive suprachoroidal hemorrhage, and retinal detachment.[Hyams, 1990 #8965] Posterior sclerotomy may or may not be successful at preventing uveal effusion.[Calhoun, 1975 #8047; Jin, 1990 #2759]
CONTRAINDICATIONS
Corneal edema is not a contraindication to ALPI when it is performed in order to break a medically unresponsive attack of angle-closure glaucoma. Extensive corneal opacification may present difficulties, because higher powers necessary to cause contraction of the iris may injure the cornea as well. Glycerin may help clear the cornea temporarily.
If the anterior chamber is flat with iris-corneal apposition, any attempt at photocoagulation will result in damage to the corneal endothelium. If the anterior chamber is very shallow, laser applications should be timed enough apart so that heat generated can dissipate.
Although ALPI has been reported to break PAS,[Wand, 1992 #1511] we have been unable to accomplish this. ALPI should not be used to relieve synechial angle closure, especially in eyes with uveitis, neovascular glaucoma, or iridocorneal-endothelial syndrome.
TECHNIQUE
ALPI is performed on an outpatient basis using topical anesthesia and an Abraham lens. Perioperative apraclonidine is administered. Shortly before treatment, 4% pilocarpine is applied topically to put maximal stretch on the iris. In eyes predisposed to a paradoxical reaction to pilocarpine, the risk is minimized by the timing of the pilocarpine. Miotics should not, however, be continued following the procedure.
Contraction burns (500 µm spot size, 0.5 second duration, and 200 to 400 mW power) are used to pull the surrounding iris tissue toward, and compact the stroma at the site of the burn (Figures 15, 16). The short-term effect appears to be related to heat shrinkage of collagen and the long-term effect secondary to contraction of a fibroblastic membrane in the region of the laser burn.[Sassani, 1993 #4718]
The aiming beam should be directed to the most peripheral portion of the iris possible. Spot placement short of the iris root is ineffective. The patient should look in the same direction as the quadrant of iris being treated. It is useful to allow a thin crescent of the aiming beam to overlap the sclera at the limbus. The surgeon should begin with 200 mW for dark irides and 300 mW for light ones and adjust the power as necessary to obtain visible stromal contraction. Contraction is accompanied by deepening of the peripheral anterior chamber at the site of the burn. If bubble formation occurs or if pigment is released, the power should be reduced. Occasionally, in light gray irides, a 200 µm spot size may be more effective.
Twenty to 24 spots are placed over 360°, leaving approximately 2 spot-diameters between each spot and avoiding large visible radial vessels if possible. Although rare, iris necrosis may occur if too many spots are placed too closely together. If this is insufficient, more spots may be given at a later time. The presence of an arcus senilis should be ignored. An extremely shallow anterior chamber and corneal edema, relative contraindications to laser iridotomy, do not preclude ALPI.
Other laser settings which have been advocated in the past, most commonly 200 µm, 0.l or 0.2 sec duration and 200 mW power, and burns placed through the angled mirror of a gonioscopy lens, often provide insufficient contraction and result in tissue vaporization. In those uncommon angles with a very sharp peripheral drop-off which do not respond well to the above treatment, one of the angled mirrors of a Goldmann or Ritch lens, a 200 µm spot size directly onto the peripheral iris can be used.
Gonioscopy should be performed to assess the effect of the procedure. Patients are treated with topical steroids four to six times daily for 3 to 5 days. IOP is monitored postoperatively as after any other anterior segment laser procedure and patients treated as necessary if a postlaser rise occurs.
Complications
Mild postoperative iritis is common and responds to topical steroid treatment. The patient may experience transient ocular irritation. Hemorrhage does not occur. A transient rise in IOP can occur as with other anterior segment laser procedures. Because ALPI is often performed on patients with extremely shallow peripheral anterior chambers, ill-defined, diffuse corneal endothelial burns may occur. We have seen only one case of corneal decompensation following ALPI in a patient with preexisting Fuchs' dystrophy. Lenticular opacification has not occurred and theoretically would be highly unlikely.
The duration of success depends on the mechanism of the cause of angle-closure. Eyes with plateau iris rarely if ever require retreatment. However, angle-closure may recur on the basis of lens enlargement with time. Pressure from the lens against the posterior iris may lead to gradual narrowing of the angle, possibly because of further anterior lens movement or to stretching of the iris stroma. Necessity for retreatment is most common in eyes in which angle-closure is due to forward lens movement, particularly malignant glaucoma. Patients in whom angle-closure results from intumescent lenses usually undergo cataract extraction. Patients should be observed gonioscopically at regular intervals and further treatment given if necessary.
Figures
Figure 1. Zeiss indentation gonioprism.
Figure 2. a. During gonioscopy with the Zeiss gonioprism, the cornea retains its normal configuration. b. During indentation, gentle pressure on the central cornea causes it to bow posteriorly, shallowing the central anterior chamber. The displaced aqueous is forced into the angle recess, open areas of appositional angle closure. Regions of synechial angle closure will remain closed.
Figure 3. a. Ultrasound biomicrograph of the anterior chamber angle in bright illumination. The cornea (C), iris (I), anterior chamber (AC), posterior chamber (PC), ciliary body (CB), lens capsule (LC), scleral spur (thin, black arrow), and Schwalbe's line (thick, black arrow) are visible. The iris is slightly convex (white arrow), consistent with relative pupillary block. Aqueous has access to the trabecular meshwork, which is between Schwalbe's line and sclera spur. b. In dim illumination, the peripheral iris has now moved against the trabecular meshwork, closing the angle.
Figure 4. Ultrasound biomicrograph of an eye with relative pupillary block. The iridocorneal angle is almost closed due to the iris convexity caused by increased pressure in the posterior chamber (PC). The ciliary sulcus (curved arrow) is normal. The arrowhead indicates the site of iridolenticular apposition. The trabecular meshwork is shown (straight arrow)
Figure 5. Goniophotograph of an appositionally closed angle in an eye with relative pupillary block (top). With gentle pressure during indentation gonioscopy, the angle opens uniformly, revealing the angle structures (bottom).
Figure 6. In more severely affected eyes, the iris convexity achieves a bombe configuration, as is present in this pseudophakic eye (I, iris; arrow, force of aqueous pressure).
Figure 7. a. Relative pupillary block angle closure prior to laser iridotomy. b. Following laser iridotomy, the iris assumes a flat configuration (white arrow) and the angle opens (black arrows at scleral spur and Schwalbe's line).
Figure 8. Typical gonioscopic appearance of plateau iris. a. Before indentation, the angle is closed to mid-trabecular meshwork. The iris assumes a characteristically flat approach to the angle. b. With indentation, the deepest displacement of the iris occurs at the lens equator. c. Diagram of an eye with plateau iris showing anterior extension of the ciliary processes, supporting the iris root against the trabecular meshwork.
Figure 9. Ultrasound biomicrograph of an eye with plateau iris which has already undergone laser iridotomy. The iris surface is flat and the chamber appears normally deep. The iris root is thick and the entire periphery of the iris is supported by large and anteriorly positioned ciliary processes.
Figure 10. In aqueous misdirection, an abnormality of the vitreociliary relationship causes a posterior diversion of aqueous into the vitreous (arrow). The resultant increased posterior segment pressure is the cause of angle-closure.
Figure 11. In some patients with a clinical diagnosis of malignant glaucoma, annular detachment of the ciliary body is the cause of the angle closure.
Figure 12. Ultrasound biomicrograph of an eye with malignant glaucoma. Anterior rotation of the ciliary processes (star) has forced the peripheral iris against the trabecular meshwork (arrowheads). A shallow supraciliary effusion is present (arrow)
Figure 13. a. In the untreated eye with pigment dispersion syndrome, the iris assumes a concave configuration (white arrow) due to pressure differential between the anterior and posterior chambers. b. Following laser iridotomy, elimination of the pressure gradient across the iris allows it to assume a planar, or flat, configuration.
Figure 14. Cross section of the iris. The anterior border layer, stroma, and pigment epithelium absorb argon laser energy differently because of differing pigmentation.
Figure 15. Correct placement of the ALPI burn in the extreme peripheral allows for contraction of the iris toward the burn and away from the angle.
Figure 16. a. Ultrasound biomicroscopic image of an eye with plateau iris prior to ALPI. b. A similar eye after ALPI. Note the compression of the iris root, creating a space between it and the trabecular meshwork.
References
1. Verhoeff FH, Bell L. The pathological effects of radiant energy on the eye. Proc Am Acad Arts Sci 1916;51:630.
2. Meyer-Schwickerath G. Erfahrungen mit der Lichtkoagulation der Metzhaut und der Iris. Doc Ophthalmol 1966;10:91.
3. McDonald JE, Light A. Photocoagulation of the iris and retina. Arch Ophthalmol 1958;60:384.
4. Hogan MF, Schwartz A. Experimental photocoagulation of the iris in guinea pigs. Am J Ophthalmol 1960;49:629.
5. Burns RP. Improvement in technique of photocoagulation of the iris. Arch Ophthalmol 1965;74:306.
6. Beckman H, et al. Laser iridectomies. Am J Ophthalmol 1971;72:393.
7. F

Re: [glaucoma] Lumigan side effects

2007-12-26 05:40:42

Hi,

I have been having alot of palpatations and hot flashes the past few weeks. I've decided to totally stop moderate drinking of alcohol in case it is making this worse.

I'm on Lumigan and it does not list palpatations as a side effect.

I see the Glauc. specialist next Weds so I suppose I should mention all this to him.

Any thoughts?

Thanks,

Lynn

Re: [glaucoma] Alphagan Side Effects

2007-12-25 22:42:35

the only way to tell is to retest twice - stop the Alphagan, see if the depression clears, start the alphagan, see if it comes back, stop it again. This is the only way to connect any unusual side effect with a drug with fair certainty.

Alphagan Side Effects

2007-12-25 12:27:52

I was put on Alphagan, as a 3rd med, in February 2004 to control my IOPs. It's been doing a good job for my IOP, but I'm wondering what it's doing to my *atypical depression*. I'm finding that I'm becoming more and more isolated. Has anyone else had a similar experience with Alphagan? Are there any other drops similar to Alphagan without the *depression* side effect? The other meds are Timolol and Xylatan.

Thanks,

Carol S

---
Outgoing mail is certified Virus Free.
Checked by AVG anti-virus system (http://www.grisoft.com).
Version: 6.0.688 / Virus Database: 449 - Release Date: 5/18/2004

Re: [glaucoma] Digest Number 1102 - Joan

2007-12-25 06:25:35

Joan,

The procedure sounds like a iridoplasty - that's one of the *safest* procedures out there according to my doctor, and the only one he would consider for me at this time.

Carol

http://www.glaucomaworld.net/english/023/e02302t.html

Laser iridoplasty
It has been suggested that if IOP cannot be controlled despite 4 hours of medical therapy, alternative treatment should be considered. The technique of argon laser iridoplasty and sector pupilloplasty were described in 1982, and offer a non-invasive method of tackling medically unresponsive PAC^(6).
The aim is to apply low power contraction burns to the iris stroma either peripherally or at the sphincter. This will draw the peripheral iris away from the trabecular meshwork, opening the angle. An Abraham's or Wise iridotomy lens should be used. The power setting is varied according to the colour and thickness of the iris. Starting at 100 mW, power is increased until stromal contraction is seen. If pigment is liberated, the power should be reduced. For iridoplasty, five to ten burns are applied as peripherally as possible in each quadrant in areas which have been found to open with compression gonioscopy (or the inferior quadrant if this is not possible).

---
Outgoing mail is certified Virus Free.
Checked by AVG anti-virus system (http://www.grisoft.com).
Version: 6.0.688 / Virus Database: 449 - Release Date: 5/18/2004

Lumigan side effects

2007-12-25 04:00:44

Lumigan: my side effects
1) my blood pressure was always in the normal range but now it is lower. I tried taking Aleve recently and my blood pressure got really low. So for me Aleve and Lumigan do got mix.
2) my eyes, nose and throat dry out
So I use lubricating eye drops, vitamin A&E ointment for the nose and cough drops for the throat
3) I am dark around the eyes, which since I am female, I can use makeup to help hide that.
4) I consider the above items to be minor and easy to live with.

eqwestart@...: In response to your question about Lumigan and heart problems.

Re: [glaucoma] Digest Number 1103

2007-12-25 02:27:33

Just off the top of my head, I've noticed that most eyedrops I've had to use
mention not to be used by nursing mothers. I'd really question it before
using eyedrops if nursing. If it came to seeing or nursing, I'd pick seeing.
I know nursing is a wonderful bonding experience, but once diagnosed that's
the time for medications, or I think so anyway. Joan W

Re: [glaucoma] New to Glaucoma at age 27

2007-12-24 14:05:10

When I was first diagnosed I had a baby that I was nursing and my concerns
were the same as yours. When I asked my doctor at the time she replied that
she had never had another patient that was of child-rearing age and
therefore didn't know if it was safe to use drops. I naturally went to see
another doctor and have been with him since. I was put on Betagan at the
time and was told to put the drops in a few hours before breastfeeding. I
double-checked with a maternity hospital and was told the same. I think
being pregnant and taking drops is more dangerous than breastfeeding as the
baby absorbs more while in the womb.
Good Luck :-)
Dora

Re: [glaucoma] Digest Number 1102

2007-12-24 11:19:00

I went to my glaucoma specialist yesterday. He said a muscle in the corner
of my eye is pushing on the rest of the delicate stuff and causing fluid to
back up and damage my optic nerves. One has a hemmorage. I'm on Timoptic XE,
Alphagan P, Azopt, Lumigan, and now Pilocarpine. Talk about a drug induced
headache. He's going to see me again on the 27th (my birthday) and do some
kind of laser that blasts the iris full of holes. I already had the one in
the meshwork to no avail and the one that put only one hole in my irises,
that helped very little for a short period. If this new laser doesn't lower
it, I need to have trabs. Does anyone know the name of the type of laser
surgery that does alot of burns at once? He said it would be harder to
tolerate than the other procedures. I found them to be painful, but not
horribly so. Don't be afraid of laser surgery. Any info is appreciated.
Thank you all for being here, too. It's much easier to bear knowing I have
this group to turn to for compassion and education about my eyes. Joan W

New to Glaucoma at age 27

2007-12-24 04:44:54

Hi, I was just diagnosed yesterday with open angle glaucoma. Am
seeing a specialist tomorrow for first time to start meds. What are
the good questions to ask? I'm only 27 and have two small children
at home and still nursing. Does anyone know which meds are safest
for breastfeeding? Thanks, mmw

Travatan: Lower blood pressure?

2007-12-23 19:53:10

I have been taking Travatan for the past month, and I am not
sure if it is the Travatan,but I have noticed some days when it is
lower than it was.
Generally in the past: when I was under stress it would be
in the low 130's/mid 80's: like 134/82.
When I was relaxed like on vacation it would be like
126/82.
It has been lately, sometimes testing as low as 117/79.
Could it be the Travatan? Being in a period of being really
scared about my eyes, I am certainly not under LOW stress,
and so measuring blood pressure that low would be unusual.
I even replaced the batteries in my monitor with brand new
ones thinking the batteries were starting to die, but that wasn't
it.
If that's the case, then that's a good "side effect".
Laurie

Re: palpitations

2007-12-23 18:45:31

Hello
Thanks for the info but in laymen's terms please - prostaglandin
analog? - please define.
Thank you,
Lynn

Re: [glaucoma] Doctors in my area

2007-12-23 09:11:37

e-mail me directly

palpitations

2007-12-23 08:21:10

It's rare and I'm not even sure it's been reported anywhere, but yes, I
have seen a few patients who complained of palpitations with one or another
prostaglandin analog.
Robert Ritch, MD
Professor of Clinical Ophthalmology
Chief, Glaucoma Service
Surgeon Director
The New York Eye and Ear Infirmary
310 East 14th Street
New York, NY 10003
Medical Director and
Chairman, Scientific Advisory Board
The Glaucoma Foundation
Private (Executive Asst: Karen Cheifetz) - Tel: 212-673-5140
kcheifetz@...
Patient Appointments - Tel: 212-477-7540
Fax: 212-420-8743
e-mail: ritchmd@...
http://www.glaucoma.net
http://www.nyee.edu

Keeping Drops cool. etc.

2007-12-23 00:21:48

Hi,

Still catching up on emails - how important is it to keep them below 77 degrees??? I never thought about this but this is the first summer I'll be using Lumigan. Never worried/thought about it with the Betagan. This has big ramifications if I want to travel. It does get up to the 100s here in the summer and my house can get as high as 90 deg. inside.

Also, I go in for a pressure recheck today. A month ago my pressure was 15/16 and my optham. measured my corneas and she said they were thin. That is an indication the pressure is higher she said according to latest info. Any thoughts on that - is 15/16 high (she said it was probably more like around 20 due to the corneas)?

I also have an appt. with the glauc. specialist next week. I also have been having little weird heart palps. I have NOTHING wrong that all the tests can detect with my heart. Lumigan is not supposed to have this effect but does anyone know about this with Lumigan - could it do this?

Thanks,Lynn

Re: Fogginess/Cloudiness in Central Vision

2007-12-22 16:27:05

Well, I am 46: and that is comparatively young: as I don't
expect to die anytime soon unless some terrible thing like
cancer suddenly hits me out of nowhere.
If so, I think that you will benefif from the advance of medical
science (assuming we don't blow the world up) that will find a way
to restore damaged and dead optical nerves. Just recently there
was an exciting story about researchers who have found a way to use
stem cells to restore nerves. And they believe this will someday
be applicable to a wide range of diseases, including glaucoma. The
leading doctors in this field are now saying that restoring the
optical nerve may well be possible within 20 years. So, be of good
cheer. Help is on the way. Dwight
I hope you are right.
Also wanted to add: in regard to my comment about sinusitis/
etc.: that not being a doctor I have no way of knowing whether
this contributed to what happened.
Laurie

Doctors in my area

2007-12-22 12:57:10

Could someone, especially Dr. Rich, give me the names of recommended glaucoma spec. in the Hartford, CT area? Thank you

Re: [glaucoma] Living with Galucoma

2007-12-22 09:20:10

Hi Mia,

thank you so much for sharing! I share most of your feelings.

long-distance hand-holding can be very comforting, it is sometimes a relief to have a "virtual" shoulder to cry on, since as you point out, most people have a blind spot, so to speak, about this issue.

I do not think it is denial. I just think the level of awareness, compared to , say, gingivitis, is very poor. I wish I could contribute in some way to helping improve the level of awareness. I keep thinking i should write a children's book, for example, in order to make people aware when they are still young enough to do something about it.

most of my friends have no comprehension of what glaucoma is. they constantly send me helpful info about macular degeneration and other related conditions, thinking it will cure my condition; and they never fail to ask me if my eyes are getting any better, if they hurt, etc...no matter how often i repeat the story, it never sinks in.....possibly because my condition is invisible to them. I have not lost my hair; my skin has not discolored; i have no prosthesis; and so it is out-of-sight-out-of-mind.

even my general practice doctors do not understand my condition. last time i had a MRI for some severe headaches i was experiencing, my doctor told me i would be happy to hear my "optic nerve" was completely normal!

i would really like there to be a big awareness campaign for glaucoma.

i guess this is just rant-n-rave day :-) tomorrow will be better

blessings,

deena
miakoda20042000 <miakoda@...

Hi,
I want to reply to this specific mail as I could have written it
myself mostly. I ( "suddenly" ) lost about 50% of my vision 18 months
ago at the age of 35. I had emergency trabeculectomy surgery which
appeared to work but now the pressures are rising again. My life has
been filled with books. On leaving university I attended an interview
at a renowned library where they asked why I wanted to work in that
environment. My answer was simply that my life is filled with books so
it's a natural choice. I worked there for 7 years, until I had a child
and needed to move frequently due to my husbands work. I too now read
frantically, trying to cram everything in before my vision is finally
lost.
My son is 6. I often wonder whether I'll be able to see his face when
he is an adult. I would dearly love to have another child but am
scared to hell about how the stress of labour may affect my vision. I
am holding on to my drivers licence by a thread, if my vision
deteriorates further I have no idea how I'll get my son to school each
day. I live in the countryside with a virtually non existent bus
service. I assume there will be help from some organisation if the
worst does happen but the thought of potential helplessness is dreadful.
People, I have found, assume that if you have an attitude of "hey,
I've lost much of my vision but I'm fine blah blah" then you have
immense mental strength. I would like to balance this scenario a
little. I have always been mentally strong and for those out there
that do become depressed and angry about their condition, this is
perfectly normal and not a reflection of weakness at all.
Furthermore, there is also the point, in my experience anyway, that
those around you assume that after the initial shock of being
diagnosed with glaucoma and losing a significant degree of vision, you
adjust and return to being who you were before that happened. In my
opinion this is another myth. As an example, how can I possibly feel
as I did before blindness struck me, I have less vision than my 71
year old mother.
I now work for an organisation closely linked with RNIB. This has
helped me a great deal and I've met many compassionate people. But
another telling fact in this regard: With the exception of my husband,
I find that my family and friends don't ask me about this new aspect
of my life. Yet another avoidance technique (sigh).
On a more positive note, what I have learned to do is appreciate many
things that I took for granted before. Being able to cook, paint a
picture with my son, write an email (!) are things that now mean much
more than they ever did.
I apologise in advance if this email sounds mostly negative but I feel
a little better for having written it!
Mia

glaucoma and heart rhythm disturbances

2007-12-22 04:23:12

Hi,

I am catching up on all my back emails and found this. I have started having heart disturbances but nothing has shown up with all the testing. I do have glaucoma or am a suspect and have cupping as well.

Please send me info.

Thanks,

Lynn

Wong <esswong@...

Please send me this information.
I was diagnosed with normal tension glaucoma about 10 years ago, but hadnt heard about this before.
best,
Eleanor
On 5/14/04 8:58 AM, "Ronnie J Schultz" <ronniejoy@...

I am new to the group and thank you all for the opportunity to learn from all of you.
I have a question- I am 48 years old and have a long history of atrial fibrillation- I was just diagnosed with normal tension glaucoma in my left eye. (I have enlarged cupping in both eyes)
I have read that there is a direct link to this type of glaucoma and heart rhythm disturbances.
I am wondering if others here in the group have some kind of glaucoma and also a history of an arrhythmia of some type. I would be interested in hearing from you.
If anyone is interested in the documentation I found on this I would be willing to forward it to you.
Thanks in advance,
Ronnie
NYC

Re: [glaucoma] Fogginess/Cloudiness in Central Vision

2007-12-21 14:05:05

Laurie, you ask if central vision loss occurs only in the late stages of glaucoma. I can only tell you that in my wife's case the symptoms of glaucoma first showed up in her central vision area. She sees virtually nothing in the center but still has peripheral vision, though, of course, that part of the vision cannot be focused. I think that the area of vision loss is related to a number of factors, including the particular patient's genetic makeup, the particular kind of glaucoma involved, the age of the patient, the medical history, etc.

Fogginess/Cloudiness in Central Vision

2007-12-21 12:09:57

I am wondering if anyone knows at what point people with
glaucoma typically experience noticeable changes in their
central vision?
Although I definitely have optic nerve changes,
and a definite peripheral visual field loss, which I guess means
it is definitely glaucoma (and this was confirmed by a glaucoma
specialist): I am still not convinced there isn't also something
else going on, and that the changes in CENTRAL vision that I am
experiencing are due to the glaucoma and not due to something else.
The entire story is that a year ago, I suddenly noticed
foggy/cloudy/grayish areas in my central vision: like two
arcs, one a little to the right of and a little above the central
area of focus, the other also to the right but a little below.
I went to my optometrist: he ran a visual field exam, which showed a
black area in the periphery but some lighter areas (i.e. less
serious areas of field loss) all over my central vision.
He sent me to a retinal specialist, who said I did NOT have
macula degeneration, but had a cataract, and "a little bit of
myopic degeneration": on qustioning, he said that what I had was NOT
the kind of myopic degeneration that was like wet macular
degeneration, that that was unlikely for me, and that the vision
loss was due to the cataract. End of act one.
I assumed he was right, and went back for my checkup a year later.
this time he said that yes, the vision loss was due to the cataract,
but he wanted me to see a glaucoma specialist due to the fact i had
so much cupping and tilting in my discs. (I am also very
nearsighted, and it is hard to tell this from glaucoma when this is
the case).
I went to the glaucoma specialist, and she diagnosed primary open
angle glaucoma: and said that the vision loss in my central vision
was due to glaucoma.
But I am wondering: isn't central vision loss supposed to happen
only at the very late stages? I do not have tunnel vision.
What I have all over, in my right eye, is as if you were looking at
a JPG or GIF file and the resolution was less than it should be:
as if some of the pixels were deleted (which I guess would be the
case if the optic nerve were transmitting only some of the
information, as is the case in glaucoma?)
I clearly have some areas in the left of my eye, near my nose, where
I am not picking things up/not seeing things: but aside from that I
have the foggy patches all over: from the distance, looking far off,
it looks like someone turned down the brightness on the monitor and
the clarity, simultaneously. Things look a little dimmer than they
should. But close up, like in reading, I can see definite areas of
grayness or fogginess. One is an arc to the left of my central
vision. The other are the two arcs I spoke about. ?When I look at a
white paper it is more obvious, and when I close my eyes, there is a
definite after image that looks like a big concentric ring and a
smaller concentric ring inside it. When I look at a blue computer
screen, these areas look brown. The glaucoma specialist said that
the central vision stuff could NOT be the cataract, as the cataract
is extremely early and cuold not possibly be responsible for that
degree of vision loss: that all I should be experiencing at this
point is glare.
I am not questioning the diagnosis, but just questioning whether
the CENTRAL vision stuff I am experiencing is due to that or
to something else. Both doctors, the glaucoma specialist AND the
retinal specialist, both said I do NOT have macular degeneration.
(thankfully: I actually was relieved to hear "glaucoma" and
"cataract" because one can be stopped, the other can be reversed).
I know eveyrone is different: and wondering whether anyone else has
experienced this pattern of having some central vision fogginess
while still being able to see a lot of the visual field (although
not all of it) and just having things dimmed down/fogged out?
I am wondering if that part of the problem could be the cataract?
It is confusing to have so many doctors. In particular, I am
irritated that it was never suggested to me to have a glaucoma
screening until a year later: wouldn't you think the original
retinal specialist would have done so? I may have lost some time
and vision from waiting a year to be treated. In addition, however,
I have reason to believe my field test was not forwarded from the
optomestrist to the opthalmologist group: and if so, that could
explain it. And I am wondering how much my specific central vision
issues were described in my chart?
My goal is on my next visit to both doctors, I will describe
SPECIFICALLY what I am seeing/not seeing.
What may be happening, might be that they really don't know exactly
WAHT is causing this. The main reason I want them to tell me, or
find out if they don't already know, is that there are issues if
anything happens to my left (good) eye: which I am considering laser
surgery for for a retinal tear which appears stable but which is
producing flashers that are gradually increasing: a sign that it
should be laser treated so it does not detach: if the fogginess in
my right eye is glaucoma, then if anything goes wrong in the surgery
on my left eye I am left with being able to drive, get around, read
slowly (because part o the fogginess cuts across a line of print):
and because of the nature of the fogginess, I actually see CLEARER
when the type is smaller so magnifying would not work. but if the
fogginess is cataract, then that means that all I have regarding
glaucoma is the peripheral areas I am not seeing too well, and that
the central stuff can be removed.
I'm not asking anyone for a diagnosis here: and I know everyone is
different: but just wondering what people's experience have been, or
your knowledge based on your research, regarding when central vision
loss happens: and is this a glaucoma pattern, or is it something
else?
Laurie
I am a little confused over which doctor is right: has anyone

Living with Galucoma

2007-12-21 05:07:57

Hi,
I want to reply to this specific mail as I could have written it
myself mostly. I ( "suddenly" ) lost about 50% of my vision 18 months
ago at the age of 35. I had emergency trabeculectomy surgery which
appeared to work but now the pressures are rising again. My life has
been filled with books. On leaving university I attended an interview
at a renowned library where they asked why I wanted to work in that
environment. My answer was simply that my life is filled with books so
it's a natural choice. I worked there for 7 years, until I had a child
and needed to move frequently due to my husbands work. I too now read
frantically, trying to cram everything in before my vision is finally
lost.
My son is 6. I often wonder whether I'll be able to see his face when
he is an adult. I would dearly love to have another child but am
scared to hell about how the stress of labour may affect my vision. I
am holding on to my drivers licence by a thread, if my vision
deteriorates further I have no idea how I'll get my son to school each
day. I live in the countryside with a virtually non existent bus
service. I assume there will be help from some organisation if the
worst does happen but the thought of potential helplessness is dreadful.
People, I have found, assume that if you have an attitude of "hey,
I've lost much of my vision but I'm fine blah blah" then you have
immense mental strength. I would like to balance this scenario a
little. I have always been mentally strong and for those out there
that do become depressed and angry about their condition, this is
perfectly normal and not a reflection of weakness at all.
Furthermore, there is also the point, in my experience anyway, that
those around you assume that after the initial shock of being
diagnosed with glaucoma and losing a significant degree of vision, you
adjust and return to being who you were before that happened. In my
opinion this is another myth. As an example, how can I possibly feel
as I did before blindness struck me, I have less vision than my 71
year old mother.
I now work for an organisation closely linked with RNIB. This has
helped me a great deal and I've met many compassionate people. But
another telling fact in this regard: With the exception of my husband,
I find that my family and friends don't ask me about this new aspect
of my life. Yet another avoidance technique (sigh).
On a more positive note, what I have learned to do is appreciate many
things that I took for granted before. Being able to cook, paint a
picture with my son, write an email (!) are things that now mean much
more than they ever did.
I apologise in advance if this email sounds mostly negative but I feel
a little better for having written it!
Mia

Re: Keeping Drops at Proper Temperature

2007-12-21 03:03:40

Sherry: I checked out the cool packs, and they sound really good:
they look from the picture like they are very light weight
and small, which is a consideration in situations like traveling on
a camping trip via flying, when excess weight means dragging
more stuff through the airport.
Laurie

RE: [glaucoma] Keeping Drops at Proper Temperature

2007-12-20 13:59:15

Laurie,
I went to Yakima, WA for a car show one summer. We stayed overnight the
first night and drove back later that day so the drops were going to be
unrefrigerated all day. I brought an ice chest, wrapped the drops in a
plastic zip bag to keep them dry and put them on top of the ice in the
chest. A small wide mouth therm